Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis

Cancer Cell International

Volumn 14, Issue 1, 2014, Pages

  Cui, Zhe ^a   Tang, Jian ^a   Chen, Jinxian ^a   Wang, Zheng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colorectal cancer; Liver metastasis; MACC 1; miRNA

Indexed keywords

,MICRORNA 1226; MESSENGER RNA; METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; MICRORNA; MICRORNA 1228; MICRORNA 1252; MICRORNA 1273D; MICRORNA 1273E; MICRORNA 1285; MICRORNA 2054; MICRORNA 497; MICRORNA 574; MICRORNA 616; MICRORNA 665; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; HCT116 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER METASTASIS; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPHEROID CELL; TUMOR INVASION; WESTERN BLOTTING;

EID: 84902536665     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-14-47     Document Type: Article

References (35)

1. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008, 371(9617):1007-1016. 10.1016/S0140-6736(08)60455-9, 2277487, 18358928.
2. Petri A, Hohn J, Balogh A, Kovách K, Andrási L, Lázár G. Surgical treatment of liver metastasis in colorectal cancer with simultaneous liver resection. Magy Onkol 2010, 54(2):125-128. 10.1556/MOnkol.54.2010.2.6, 20576588.
3. Huh JW, Cho CK, Kim HR, Kim YJ. Impact of resection for primary colorectal cancer on outcomes in patients with synchronous colorectal liver metastases. J Gastrointest Surg 2010, 14(8):1258-1264. 10.1007/s11605-010-1250-7, 20544397.
4. Kornprat P, DeMatteo RP, Blumgart LH, Jarnagin WR. Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Ann Surg Oncol 2011, 18(4):1096-1103. 10.1245/s10434-010-1409-1, 21042942.
5. Fidler IJ. The pathogenesis of cancer metastasis: the'seed and soil'hypothesis revisited. Nat Rev Cancer 2003, 3(6):453-458. 10.1038/nrc1098, 12778135.
6. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133(4):704-715. 10.1016/j.cell.2008.03.027, 2728032, 18485877.
7. Kitayama J, Nagawa H, Tsuno N, Osada T, Hatano K, Sunami E, Saito H, Muto T. Laminin mediates tethering and spreading of colon cancer cells in physiological shear flow. Br J Cancer 1999, 80(12):1927. 10.1038/sj.bjc.6690622, 2363138, 10471041.
8. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998, 279(5349):377-380. 10.1126/science.279.5349.377, 9430587.
9. Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W, Schlag PM. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2008, 15(1):59-67.
10. Yang J, Mani SA, Weinberg RA. Exploring a new twist on tumor metastasis. Cancer Res 2006, 66(9):4549-4552. 10.1158/0008-5472.CAN-05-3850, 16651402.
11. Paschos KA, Canovas D, Bird NC. The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell Signal 2009, 21(5):665-674. 10.1016/j.cellsig.2009.01.006, 19167485.
12. Li C, Wu JJ, Hynes M, Dosch J, Sarkar B, Welling TH, Pasca di Magliano M, Simeone DM. c-Met is a marker of pancreatic cancer stem cells and therapeutic target. Gastroenterology 2011, 141(6):2218-2227. e2215, 10.1053/j.gastro.2011.08.009, 21864475.
13. Li Y, Li A, Glas M, Lal B, Ying M, Sang Y, Xia S, Trageser D, Guerrero-Cázares H, Eberhart CG. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc Natl Acad Sci 2011, 108(24):9951-9956. 10.1073/pnas.1016912108, 3116406, 21628563.
14. Zhang Y, Wang Z, Chen M, Peng L, Wang X, Ma Q, Ma F, Jiang B. MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol Cancer 2012, 11(1):23. 10.1186/1476-4598-11-23, 3351020, 22533346.
15. Migliore C, Martin V, Leoni VP, Restivo A, Atzori L, Petrelli A, Isella C, Zorcolo L, Sarotto I, Casula G. MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clin Cancer Res 2012, 18(3):737-747. 10.1158/1078-0432.CCR-11-1699, 22179665.
16. Cho W. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2010, 42(8):1273-1281. 10.1016/j.biocel.2009.12.014, 20026422.
17. Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Perilli L, Rossi E, Esposito G, Rugge M, Pilati P. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 2013, 14(1):589. 10.1186/1471-2164-14-589, 3766699, 23987127.
18. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced Accumulation of Specific MicroRNAs in Colorectal Neoplasia11Note: Susan M. O'Connor and Nicholas G. van Holst Pellekaan contributed equally to this work. Mol Cancer Res 2003, 1(12):882-891.
19. Cho W, Chow AS, Au JS. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer 2009, 45(12):2197-2206. 10.1016/j.ejca.2009.04.039, 19493678.
20. Schetter AJ, Nguyen GH, Bowman ED, Mathé EA, Yuen ST, Hawkes JE, Croce CM, Leung SY, Harris CC. Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res 2009, 15(18):5878-5887. 10.1158/1078-0432.CCR-09-0627, 2745503, 19737943.
21. Kalabus JL, Cheng Q, Blanco JG. MicroRNAs differentially regulate carbonyl reductase 1 (CBR1) gene expression dependent on the allele status of the common polymorphic variant rs9024. PLoS One 2012, 7(11):e48622. 10.1371/journal.pone.0048622, 3486798, 23133646.
22. Ji S, Ye G, Zhang J, Wang L, Wang T, Wang Z, Zhang T, Wang G, Guo Z, Luo Y. miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer. Gut 2013, 62(5):716-726. 10.1136/gutjnl-2011-301083, 3618686, 22490519.
23. Karlsson H, Fryknäs M, Larsson R, Nygren P. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. Exp Cell Res 2012, 318(13):1577-1585. 10.1016/j.yexcr.2012.03.026, 22487097.
24. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449(7163):682-688. 10.1038/nature06174, 17898713.
25. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451(7175):147-152. 10.1038/nature06487, 2782491, 18185580.
26. Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y, Pertsemlidis A. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev 2009, 23(18):2140-2151. 10.1101/gad.1820209, 2751985, 19759262.
27. Saydam O, Shen Y, Würdinger T, Senol O, Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens RM. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/β-catenin signaling pathway. Mol Cell Biol 2009, 29(21):5923-5940. 10.1128/MCB.00332-09, 2772747, 19703993.
28. Sachdeva M, Mo Y-Y. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 2010, 70(1):378-387. 10.1158/0008-5472.CAN-09-2021, 2805032, 19996288.
29. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 2008, 28(17):5369-5380. 10.1128/MCB.00479-08, 2519720, 18591254.
30. Stein U, Dahlmann M, Walther W. MACC1-more than metastasis? Facts and predictions about a novel gene. J Mol Med 2010, 88(1):11-18. 10.1007/s00109-009-0537-1, 19787327.
31. Stein U, Smith J, Walther W, Arlt F. MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle 2009, 8(15):2467-2469. 10.4161/cc.8.15.9018, 19556890.
32. Arlt F, Stein U. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 2009, 41(12):2356-2359. 10.1016/j.biocel.2009.08.001, 19666136.
33. Birchmeier C, Birchmeier W, Gherardi E, Woude GFV. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003, 4(12):915-925. 10.1038/nrm1261, 14685170.
34. Zeng Z-S, Weiser MR, Kuntz E, Chen C-T, Khan SA, Forslund A, Nash GM, Gimbel M, Yamaguchi Y, Culliford AT. c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. Cancer Lett 2008, 265(2):258-269. 10.1016/j.canlet.2008.02.049, 18395971.
35. Larsen CA, Dashwood RH. Suppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: Minor role of hydrogen peroxide. Biochem Biophys Res Commun 2009, 389(3):527-530. 10.1016/j.bbrc.2009.09.019, 2761952, 19744467.